ReviewFrontiers in cell and developmental biology2023
Artificial intelligence technology for myopia challenges: A review.
Review in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.
- Artificial intelligence in ophthalmology: a bibliometric analysis of the 5-year trends in literature.Frontiers in medicine · 2025Pooled it
- The application of artificial intelligence in myopia prediction for children and adolescents: a review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Review
- Impact of artificial intelligence on the availability, accessibility, acceptability and quality of ophthalmic disease screening services: a scoping review.The British journal of ophthalmology · 2026Article
- Article
- Artificial intelligence for myopia: Current update and concern.Indian journal of ophthalmology · 2026Article
- Exploring Machine Learning Models for Vault Safety in ICL Implantation: A Comparative Analysis of Regression and Classification Models.Ophthalmology and therapy · 2025Article
- Quantitative evaluation and optimization of AI policy and regulatory texts for smart healthcare.Frontiers in public health · 2025Article
- New Horizons in Myopia Management: Bridging Epidemiology and Clinical Innovation.Vision (Basel, Switzerland) · 2024Article
- Self-supervised learning-enhanced deep learning method for identifying myopic maculopathy in high myopia patients.iScience · 2024Article
- RETFound-enhanced community-based fundus disease screening: real-world evidence and decision curve analysis.NPJ digital medicine · 2024Article
- Deep learning prediction of steep and flat corneal curvature using fundus photography in post-COVID telemedicine era.Medical & biological engineering & computing · 2024Article
- Insights into artificial intelligence in myopia management: from a data perspective.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024Review
- Research progress in artificial intelligence assisted diabetic retinopathy diagnosis.International journal of ophthalmology · 2023Article
- Shaping the future of myopia with artificial intelligence: Mapping trends and promising directions.Advances in ophthalmology practice and researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myopia is a significant global health concern and affects human visual function, resulting in blurred vision at a distance. There are still many unsolved challenges in this field that require the help of new technologies. Currently, artificial intelligence (AI) technology is dominating medical image and data analysis and has been introduced to address challenges in the clinical practice of many ocular diseases. AI research in myopia is still in its early stages. Understanding the strengths and limitations of each AI method in specific tasks of myopia could be of great value and might help us to choose appropriate approaches for different tasks. This article reviews and elaborates on the technical details of AI methods applied for myopia risk prediction, screening and diagnosis, pathogenesis, and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.